133
Participants
Start Date
November 30, 2007
Primary Completion Date
June 30, 2009
Study Completion Date
June 30, 2009
n-3 PUFAs
1.0 g gelatin capsules containing 850 to 882 mg of EPA and DHA ethyl esters in the average ratio EPA/DHA of 0.9:1.5 The treatment dose was five capsules daily for the first month followed by two capsules daily for the rest of the study.
Placebo
1.0 g gelatin capsules containing olive oil. The treatment dose was five capsules daily for the first month followed by two capsules daily for the rest of the study
Arrhytmias and Heart failure Unit-Spedali Civili Hospital, Brescia
Università degli Studi di Brescia
OTHER